Peace D J, Kern D E, Schultz K R, Greenberg P D, Cheever M A
Department of Medicine, University of Washington, Seattle 98195.
J Immunol. 1988 May 15;140(10):3679-85.
The purpose of the current study was to characterize lymphokine-activated killer (LAK) activity induced with IL-4/B cell stimulatory factor-1 and to compare IL-4-induced LAK activity with IL-2-induced LAK activity. Culture of murine lymphocytes with high concentrations of IL-4 induced nonspecific lytic activity against a wide variety of tumors. Lytic activity induced by IL-4 increased with increasing concentrations of IL-4 over the range of 1.0 to 25 ng/ml. The kinetics of LAK induction by IL-4 and IL-2 were similar; however, IL-4 was less effective than IL-2 in maintaining lytic activity for longer culture periods and provided lower viable cell yields than did IL-2. Similar to IL-2, IL-4 induced blastogenesis and the generation of large granular lymphocytes, all LAK activity observed was exclusively associated with the large granular lymphocyte fraction, and the cytolytic effector cells were heterogeneous in regards to cell surface phenotype. The majority of IL-4-induced lytic activity was associated with mutually exclusive NK-like (i.e., NK-1.1+ Lyt-2-) and T cell-like (i.e., NK-1.1- Lyt-2+) LAK cells. The precursors for each subset were distinct and expressed the asialo-GM1+ Lyt-2- and the asialo-GM1+ Lyt-2+ phenotypes, respectively. Although IL-4-induced LAK effector cells were morphologically and phenotypically similar to IL-2-induced LAK cells, IL-2 generated equivalent numbers of T cell-like and NK-like LAK cells, whereas IL-4 generated 3.5-fold more T cell-like LAK cells than NK-like LAK cells. It might eventually be possible to exploit the preferential activation of T cell-like LAK by IL-4 for therapeutic advantage.
本研究的目的是表征由白细胞介素-4/ B细胞刺激因子-1诱导的淋巴因子激活的杀伤细胞(LAK)活性,并将白细胞介素-4诱导的LAK活性与白细胞介素-2诱导的LAK活性进行比较。用高浓度的白细胞介素-4培养小鼠淋巴细胞可诱导出针对多种肿瘤的非特异性溶解活性。在1.0至25 ng/ml范围内,白细胞介素-4诱导的溶解活性随白细胞介素-4浓度的增加而增强。白细胞介素-4和白细胞介素-2诱导LAK的动力学相似;然而,在较长的培养期内,白细胞介素-4在维持溶解活性方面不如白细胞介素-2有效,且其活细胞产量低于白细胞介素-2。与白细胞介素-2相似,白细胞介素-4诱导细胞增殖和大颗粒淋巴细胞的产生,所有观察到的LAK活性都仅与大颗粒淋巴细胞部分相关,并且溶细胞效应细胞在细胞表面表型方面是异质的。大多数白细胞介素-4诱导的溶解活性与相互排斥的自然杀伤细胞样(即NK-1.1 + Lyt-2-)和T细胞样(即NK-1.1- Lyt-2 +)LAK细胞相关。每个亚群的前体细胞是不同的,分别表达脱唾液酸GM1 + Lyt-2-和脱唾液酸GM1 + Lyt-2 +表型。尽管白细胞介素-4诱导的LAK效应细胞在形态和表型上与白细胞介素-2诱导的LAK细胞相似,但白细胞介素-2产生的T细胞样和自然杀伤细胞样LAK细胞数量相当,而白细胞介素-4产生的T细胞样LAK细胞比自然杀伤细胞样LAK细胞多3.5倍。最终有可能利用白细胞介素-4对T细胞样LAK的优先激活来获得治疗优势。